Should Preschool Wheezers Ever Be Treated with Inhaled Corticosteroids?

ABSTRACT

The syndrome of preschool wheeze commonly regresses completely in the preschool years, but it may lead to prolonged symptoms and established asthma. Although epidemiological studies have established that there are several different phenotypes, it is currently impossible to assign the majority of wheezing preschool children to a phenotype prospectively. Bronchoalveolar lavage studies have shown an increase in total cellular inflammation in the youngest, symptomatic children, and that in older preschool children the neutrophil is the predominant inflammatory cell in the airway. Endobronchial biopsy studies have shown that eosinophilic inflammation and structural airway wall changes are absent in symptomatic infants but appear in severe wheezers by the age of 3 years. Treatment guidelines are not evidence based in this age group and frequently do not appear to consider either the likely pathology or the different patterns of symptoms. Pure virus-associated symptoms may be treated with intermittent β-2 agonist or anticholinergics by inhalation. If this fails, intermittent oral leukotriene receptor antagonists or short courses of very high dose inhaled corticosteroids could be considered. The role of oral corticosteroids is highly debatable in young children with virus-associated wheeze. Prophylactic therapy may be considered for chronic intermittent symptoms (interval symptoms between acute episodes). The choices are oral leukotriene receptor antagonists, or inhaled corticosteroids, which should be introduced in a three-stage protocol to avoid overtreating the child with evanescent symptoms. Because the natural history of preschool wheeze is one of improvement, treatment should be tapered after a period of stability. Unfortunately, neither corticosteroids nor any other currently available therapy modifies the long-term outcome of preschool wheeze. In conclusion, corticosteroid treatment may have a small role in preschool wheeze, in particular for those thought to have early asthma, but the uncritical application of recommendations that are appropriate for older children and adults with asthma has led to widespread overuse of these medications. There is an urgent need for better treatment of preschool wheeze.

Asthma - leukotriene receptor antagonist - eosinophil - neutrophil - evidence-based guideline - bronchoalveolar lavage - endobronchial biopsy

REFERENCES

• 1 British Thoracic Society. Scottish Intercollegiate Guidelines Network . British guideline on the management of asthma.  Thorax. 2003;  58(Suppl 1) i1-i94
• 2 Payne D, Saglani S, Suri R, Hall P, Wilson N, Bush A. Asthma: beyond the guidelines.  Curr Paediatr. 2004;  14 336-346
• 3 Stein R T, Holberg C J, Morgan W J et al.. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood.  Thorax. 1997;  52 946-952
• 4 Martinez F D, Morgan W J, Wright A L et al.. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.  N Engl J Med. 1988;  319 1112-1117
• 5 Brooke A M, Lambert P C, Burton P R, Clarke C, Luyt D K, Simpson H. The natural history of respiratory symptoms in preschool children.  Am J Respir Crit Care Med. 1995;  152 1872-1878
• 6 Morgan W J, Stern D A, Sherrill D L et al.. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence.  Am J Respir Crit Care Med. 2005;  172 1253-1258
• 7 Turner S W, Palmer L J, Rye P J et al.. The relationship between infant airway function, childhood airway responsiveness, and asthma.  Am J Respir Crit Care Med. 2004;  169 921-927
• 8 Turner S W, Palmer L J, Rye P J et al.. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years.  Am J Respir Crit Care Med. 2002;  165 1294-1298
• 9 Lowe L A, Simpson A, Woodcock A, Morris J, Murray C S, Custovic A. NAC Manchester Asthma and Allergy Study Group . Wheeze phenotypes and lung function in preschool children.  Am J Respir Crit Care Med. 2005;  171 231-237
• 10 Sears M R, Greene J M, Willan A R et al.. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood.  N Engl J Med. 2003;  349 1414-1422
• 11 Oswald H, Phelan P D, Lanigan A et al.. Childhood asthma and lung function in mid-adult life.  Pediatr Pulmonol. 1997;  23 14-20
• 12 Stick S M, Burton P R, Gurrin L, Sly P D, LeSouef P N. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants.  Lancet. 1996;  348 1060-1064
• 13 Lodrup-Carlsen K C, Jaakkola J J, Nafstad P, Carlsen K H. In utero exposure to cigarette smoking influences lung function at birth.  Eur Respir J. 1997;  10 1774-1779
• 14 Young S, LeSouef P N, Geelhoed G C et al.. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy.  N Engl J Med. 1991;  324 1168-1173
• 15 Gilliland F D, Gauderman W J, Vora H, Rappaport E, Dubeau L. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth.  Am J Respir Crit Care Med. 2002;  166 710-716
• 16 Kabesch M, Hoefler C, Carr D, Leupold W, Weiland S K, von Mutius E. Glutathione S transferase deficiency and passive smoking increase childhood asthma.  Thorax. 2004;  59 569-573
• 17 Gilliland F D, Li Y F, Dubeau L et al.. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children.  Am J Respir Crit Care Med. 2002;  166 457-463
• 18 Sasaki S, Kondo T, Sata F et al.. Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects.  Mol Hum Reprod. 2006;  12 77-83
• 19 Lum S, Hoo A F, Dezateux C et al.. The association between birthweight, sex, and airway function in infants of nonsmoking mothers.  Am J Respir Crit Care Med. 2001;  164 2078-2084
• 20 Hoo A F, Stocks J, Lum S et al.. Development of lung function in early life: influence of birth weight in infants of nonsmokers.  Am J Respir Crit Care Med. 2004;  170 527-533
• 21 Kedda M A, Lose F, Duffy D, Bell E, Thompson P J, Upham J. The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.  Thorax. 2005;  60 211-214
• 22 Cleveland M G, Gorham J D, Murphy T L et al.. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.  Infect Immun. 1996;  64 1906-1912
• 23 Eder W, Klimecki W, Yu L et al.. Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments.  J Allergy Clin Immunol. 2005;  116 601-607
• 24 Balfour-Lynn I M, Valman B, Wellings R, Webster A D, Taylor G W, Silverman M. Tumour necrosis factor α and leukotriene E4 production in wheezy infants.  Clin Exp Allergy. 1993;  24 121-126
• 25 van Schaik S M, Tristram D A, Nagpal I S, Hintz K M, Welliver II R C, Welliver R C. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing.  J Allergy Clin Immunol. 1999;  103 630-636
• 26 Kumlin M. Measurement of leukotrienes in the urine: strategies and application.  Allergy. 1997;  52 124-135
• 27 Oommen A, Grigg J. Urinary leukotriene E4 in preschool children with acute clinical viral wheeze.  Eur Respir J. 2003;  21 149-154
• 28 Oymar K. High levels of urinary eosinophil protein X in young asthmatic children predict persistent atopic asthma.  Pediatr Allergy Immunol. 2001;  12 312-317
• 29 Oommen A, McNally T, Grigg J. Eosinophil activation and preschool wheeze.  Thorax. 2003;  58 876-879
• 30 Oommen A, Patel R, Browning M, Grigg J. Systemic neutrophil activation in acute preschool viral wheeze.  Arch Dis Child. 2003;  88 529-531
• 31 in't-Veen J C, Grootendorst D C, Bel E et al.. CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects.  Clin Exp Allergy. 1998;  28 606-615
• 32 Grigg J, Riedler J, Robertsob C F. Bronchoalveolar lavage cellularity and soluble intercellular adhesion molecule-1 in children with colds.  Pediatr Pulmonol. 1999;  28 109-116
• 33 Brightling C E, Bradding P, Symon F A, Holgate S T, Wardlaw A J, Pavord I D. Mast-cell infiltration of airway smooth muscle in asthma.  N Engl J Med. 2002;  346 1699-1705
• 34 van den Toorn L M, Overbeek S E, de Jongste J C, Leman K, Hoogsteden H C, Prins J B. Airway inflammation is present during clinical remission of atopic asthma.  Am J Respir Crit Care Med. 2001;  164 2107-2113
• 35 Yasui K, Kobayashi N, Yamazaki T et al.. Neutrophilic inflammation in childhood bronchial asthma.  Thorax. 2005;  60 704-705
• 36 Villa J R, Garcia G, Rueda S, Nogales A. Serum eosinophilic cationic protein may predict clinical course of wheezing in young children.  Arch Dis Child. 1998;  78 448-452
• 37 Koller D Y, Wojnarowski C, Herkner K R et al.. High levels of eosinophilic cationic protein in wheezing infants predict the development of asthma.  J Allergy Clin Immunol. 1997;  99 752-756
• 38 Schellhase D E, Fawcett D D, Schutze G E et al.. Clinical utility of flexible bronchoscopy and bronchoalveolar lavage in young children with recurrent wheezing.  J Pediatr. 1998;  132 312-318
• 39 Krawiec M E, Westcott J Y, Wei Chu H et al.. Persistent wheezing in very young children is associated with lower respiratory inflammation.  Am J Respir Crit Care Med. 2001;  163 1338-1343
• 40 Le Bourgeois M, Goncalves M, Le Clainche L et al.. Bronchoalveolar cells in children < 3 years old with severe recurrent wheezing.  Chest. 2002;  122 791-797
• 41 Marguet C, Jouen-Boedes F, Dean T P et al.. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis.  Am J Respir Crit Care Med. 1999;  159 1533-1540
• 42 Marguet C, Dean T P, Warner J O. Soluble intercellular adhesion molecule-1 (sICAM-1) and interferon-gamma in bronchoalveolar lavage fluid from children with airway diseases.  Am J Respir Crit Care Med. 2000;  162 1016-1022
• 43 Leigh R, Belda J, Kelly M M et al.. Eosinophil cationic protein relates to sputum neutrophil counts in healthy subjects.  J Allergy Clin Immunol. 2000;  106 593-594
• 44 Benson M, Strannegard I L, Strannegard O et al.. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-, IL-1β, TNF- or neutrophils.  J Allergy Clin Immunol. 2000;  106 307-312
• 45 Balfour-Lynn I M, Valman B, Silverman M, Webster A DB. Nasal IgA response in wheezy infants.  Arch Dis Child. 1993;  68 472-476
• 46 Azevedo I, de Blic J, Scheinmann P, Vargaftig B B, Bachelet M. Enhanced arachidonic acid metabolism in macrophages from wheezy infants: modulation by dexamethasone.  Am J Respir Crit Care Med. 1995;  152 1208-1214
• 47 Azevedo I, de Blic J, Dumarey C H, Scheinmann P, Vargaftig B B, Bachelet M. Increased spontaneous release of tumour necrosis factor-α by alveolar macrophages from wheezy infants.  Eur Respir J. 1997;  10 1767-1773
• 48 Stevenson E C, Turner G, Heaney L G et al.. Bronchoalveolar lavage findings suggest two different forms of childhood asthma.  Clin Exp Allergy. 1997;  27 1027-1035
• 49 Saglani S, Malmstrom K, Pelkonen A S et al.. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction.  Am J Respir Crit Care Med. 2005;  171 722-727
• 50 Saglani S, Payne D N, Nicholson A G et al.. The pathology of severe preschool wheeze.  Thorax. 2005;  60(Suppl 11) ii5
• 51 Saglani S, McKenzie S A, Bush A, Payne D N. A video questionnaire identifies upper airway abnormalities in pre-school children with reported wheeze.  Arch Dis Child. 2005;  90 961-964
• 52 Saglani S, Molyneux C, Gong H et al.. Ultrastructure of the reticular basement membrane in asthmatic adults children and infants.  Eur Respir J. 2006;  28 505-512
• 53 Saglani S, Nicholson A, Scallan M et al.. Investigation of young children with severe recurrent wheeze: any clinical benefit?.  Eur Respir J. 2006;  27 29-35
• 54 Castro-Rodriguez J A, Holberg C J, Wright A L, Martinez F D. A clinical index to define risk of asthma in young children with recurrent wheezing.  Am J Respir Crit Care Med. 2000;  162 1403-1406
• 55 Burr M L, Merrett T G, Dunstan F D, Maguire M J. The development of allergy in high-risk children.  Clin Exp Allergy. 1997;  27 1247-1253
• 56 Cook D G, Strachan D P. Health effects of passive smoking-10: summary of effects of parental smoking on the respiratory health of children and implications for research.  Thorax. 1999;  54 357-366
• 57 Chalmers G W, Macleod K J, Little S A, Thomson L J, McSharry C P, Thomson N C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.  Thorax. 2002;  57 226-230
• 58 Chaudhuri R, Livingston E, McMahon A D, Thomson L, Borland W, Thomson N C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma.  Am J Respir Crit Care Med. 2003;  168 1308-1311
• 59 Tomlinson J E, McMahon A D, Chaudhuri R, Thompson J M, Wood S F, Thomson N C. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma.  Thorax. 2005;  60 282-287
• 60 Grigg J, Riedler J, Robertson C F. Soluble intercellular adhesion molecule-1 in the bronchoalveolar lavage fluid of normal children exposed to parental cigarette smoke.  Eur Respir J. 1999;  13 810-813
• 61 Kam J C, Szefler S J, Surs W, Sher E R, Leung D Y. Combination of IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T-cell response to glucocorticoids.  J Immunol. 1993;  151 3460-3466
• 62 Sulakvelidze I, Inman M D, Rerecich T, O'Byrne P M. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics.  Eur Respir J. 1998;  11 821-827
• 63 Lowe L A, Simpson A, Woodcock A, Morris J, Murray C S, Custovic A. NAC Manchester Asthma and Allergy Study Group . Wheeze phenotypes and lung function in preschool children.  Am J Respir Crit Care Med. 2005;  171 231-237
• 64 Holgate S T. Inflammation and remodelling in asthma and allied disorders: summary and conclusions.  Clin Exp Allergy. 2001;  1 ix-xiii
• 65 Langley S J, Goldthorpe S, Craven M, Woodcock A, Custovic A. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects.  Thorax. 2005;  60 17-21
• 66 Green R M, Custovic A, Sanderson G, Hunter J, Johnston S L, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study.  BMJ. 2002;  324 763-766
• 67 Murray C S, Poletti G, Kebadze T et al.. A study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospitalization in children.  Thorax. 2006;  61 376-382
• 68 Bush A. Coughs and wheezes spread diseases: but what about the environment?.  Thorax. 2006;  61 367-369
• 69 Haahtela T, Jarvinen M, Kava T et al.. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.  N Engl J Med. 1991;  325 388-392
• 70 Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.  Respir Med. 1994;  88 373-381
• 71 Boushey H A, Sorkness C A, King T S National Heart, Lung, and Blood Institute's Asthma Clinical Research Network et al. Daily versus as-needed corticosteroids for mild persistent asthma.  N Engl J Med. 2005;  352 1519-1528
• 72 CAMP study . Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group.  N Engl J Med. 2000;  343 1054-1063
• 73 van Essen-Zandvliet E E, Hughes M D, Waalkens H J, Duiverman E J, Pocock S J, Kerrebijn K F. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.  Am Rev Respir Dis. 1992;  146 547-554
• 74 Guilbert T W, Morgan W J, Zeiger R S et al.. Long-term inhaled corticosteroids in preschool children at high risk for asthma.  N Engl J Med. 2006;  354 1985-1997
• 75 Murray C S, Woodcock A, Langley S J, Morris J, Custovic A. for the IFWIN Study Team . Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy Infants (IFWIN): double blind, randomised, controlled study.  Lancet. 2006;  368 754-762
• 76 van Essen-Zandvliet E E, Hughes M D, Waalkens H J, Duiverman E J, Kerrebijn K F. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group.  Eur Respir J. 1994;  7 63-68
• 77 Meagher L C, Cousin J M, Seckl J R, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.  J Immunol. 1996;  156 4422-4428
• 78 Durham S R, Walker S M, Varga E M et al.. Long-term clinical efficacy of grass-pollen immunotherapy.  N Engl J Med. 1999;  341 468-475
• 79 ETAC study group . Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo controlled trial.  Pediatr Allergy Immunol. 1998;  9 116-124
• 80 Bisgaard H, Nielsen K G. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children.  Am J Respir Crit Care Med. 2000;  162 187-190
• 81 Bisgaard H, Zielen S, Garcia-Garcia M L et al.. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.  Am J Respir Crit Care Med. 2005;  171 315-322
• 82 Robertson C, Price D, Henry R et al.. Short-course montelukast for intermittent asthma: a randomized controlled trial.  Am J Respir Crit Care Med. 2007;  175 323-329
• 83 Dockhorn R J, Baumgartner R A, Leff J A et al.. Comparison of the effects of intravenous and oral montelukast on airway function: a double-blind, placebo-controlled, three-period, crossover study in asthmatic patients.  Thorax. 2000;  55 260-265
• 84 Camargo Jr C A, Smithline H A, Malice M P, Green S A, Reiss T F. A randomized controlled trial of intravenous montelukast in acute asthma.  Am J Respir Crit Care Med. 2003;  167 528-533
• 85 Primhak R A, Smith C M, Yong S C et al.. The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study.  Eur Respir J. 1999;  13 78-81
• 86 Nielsen K G, Bisgaard H. Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer.  Am J Respir Crit Care Med. 2001;  164 256-259
• 87 Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children.  Arch Dis Child. 1995;  72 317-320
• 88 Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide.  Arch Dis Child. 1993;  68 85-87
• 89 Thibeault D W, Heimes B, Rezaiekhaligh M, Mabry S. Chronic modification of lung and heart development in glucocorticoid treated newborn rats exposed to hyperoxia or room air.  Pediatr Pulmonol. 1993;  16 81-88
• 90 Tschanz S A, Damke B M, Burri P H. Influence of postnatally administered glucocorticoids on rat lung growth.  Biol Neonate. 1995;  68 229-245
• 91 Langston C, Kida K, Reed M, Thurlbeck W M. Human lung growth in late gestation and in the neonate.  Am Rev Respir Dis. 1984;  129 607-613
• 92 Pao C S, McKenzie S A. Randomized controlled trial of fluticasone in preschool children with intermittent wheeze.  Am J Respir Crit Care Med. 2002;  166 945-949
• 93 Nielsen K G, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children.  Am J Respir Crit Care Med. 2000;  162 1500-1506
• 94 Chavasse R J, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone.  Arch Dis Child. 2001;  85 143-148
• 95 Hofhuis W, van der Wiel E C, Nieuwhof E M et al.. Anti-Inflammatory Treatment in Infants with Recurrent Wheeze (AIR) Study Group: efficacy of fluticasone propionate on lung function and symptoms in wheezy infants.  Am J Respir Crit Care Med. 2005;  171 328-333
• 96 Rodrigo G J. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma.  Am J Respir Crit Care Med. 2005;  171 1231-1236
• 97 Estrada-Reyes E, Del Rio-Navarro B E, Rosas-Vargas M A, Nava-Ocampo A A. Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma.  Pediatr Allergy Immunol. 2005;  16 609-614
• 98 Bisgaard H, Hermansen M N, Loland L, Halkjaer L B, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing.  N Engl J Med. 2006;  354 1998-2005
• 99 Oommen A, Lambert P C, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial.  Lancet. 2003;  362 1433-1438
• 100 Bush A, Rubin B K. Macrolides as biologic response modifiers in cystic fibrosis and bronchiectasis.  Semin Respir Crit Care Med. 2003;  24 737-747
• 101 Jaffe A, Bush A. Macrolides in cystic fibrosis. In: BK Rubin, J Tamaoki Progress in Inflammation Research: Antibiotics as Anti-inflammatory and Immunomodulatory Agents. Basel; Birkhauser Verlag 2005: 167-191
• 102 Yasui K, Agematsu K, Shinozaki K et al.. Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism.  J Leukoc Biol. 2000;  67 529-535
• 103 Goldbart A D, Goldman J L, Veling M C, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children.  Am J Respir Crit Care Med. 2005;  172 364-370
• 104 Chen S T, Lu K H, Sun H L, Chang W T, Lue K H, Chou M C. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.  Pediatr Allergy Immunol. 2006;  17 49-54
• 105 Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study.  Am J Respir Crit Care Med. 1999;  160 126-131
• 106 Todd G R, Acerini C L, Ross-Russell R, Zahra S, Warner J T, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.  Arch Dis Child. 2002;  87 457-461